Literature DB >> 22609908

Healthy volunteer registries and ethical research principles.

E A Kupetsky-Rincon1, W K Kraft.   

Abstract

The dual enrolling of phase I volunteers is a potential risk to subjects. It can also distort study results, threaten study validity, and possibly cause harm to future patients. Existing subject registries differ in structure, funding, and governance. Although the choice of the ideal system is driven by the scope of the risk and the funding mechanism, and is ultimately a value judgment of freedom versus paternalism, none of the registries significantly impinges on the tenets of ethically based research.

Entities:  

Mesh:

Year:  2012        PMID: 22609908      PMCID: PMC5164923          DOI: 10.1038/clpt.2012.32

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Repeat participation among normal healthy research volunteers: professional guinea pigs in clinical trials?

Authors:  Carl L Tishler; Suzanne Bartholomae
Journal:  Perspect Biol Med       Date:  2003       Impact factor: 1.416

2.  A new job: research volunteer?

Authors:  Giovan Maria Zanini; Claudio Marone
Journal:  Swiss Med Wkly       Date:  2005-05-28       Impact factor: 2.193

3.  Adverse events in phase-I studies: a report in 1015 healthy volunteers.

Authors:  M Sibille; N Deigat; A Janin; S Kirkesseli; D V Durand
Journal:  Eur J Clin Pharmacol       Date:  1998-03       Impact factor: 2.953

4.  A national registry for healthy volunteers in phase 1 clinical trials.

Authors:  David B Resnik; Greg Koski
Journal:  JAMA       Date:  2011-03-15       Impact factor: 56.272

5.  Balancing justice and autonomy in clinical research with healthy volunteers.

Authors:  N E Kass; R Myers; E J Fuchs; K A Carson; C Flexner
Journal:  Clin Pharmacol Ther       Date:  2007-04-04       Impact factor: 6.875

  5 in total
  3 in total

1.  Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.

Authors:  Heather B Edelblute; Jill A Fisher
Journal:  J Empir Res Hum Res Ethics       Date:  2015-01-20       Impact factor: 1.742

2.  Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

Authors:  Jill A Fisher
Journal:  Sci Technol Human Values       Date:  2015-03-01

3.  Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research.

Authors:  Rebecca L Walker; Marci D Cottingham; Jill A Fisher
Journal:  J Med Philos       Date:  2018-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.